123 related articles for article (PubMed ID: 30528740)
1. Structural basis for renal cancer by the dynamics of pVHL-dependent JADE1 stabilization and β-catenin regulation.
Shafique S; Rashid S
Prog Biophys Mol Biol; 2019 Aug; 145():65-77. PubMed ID: 30528740
[TBL] [Abstract][Full Text] [Related]
2. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.
Chitalia VC; Foy RL; Bachschmid MM; Zeng L; Panchenko MV; Zhou MI; Bharti A; Seldin DC; Lecker SH; Dominguez I; Cohen HT
Nat Cell Biol; 2008 Oct; 10(10):1208-16. PubMed ID: 18806787
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent.
Zhou MI; Wang H; Foy RL; Ross JJ; Cohen HT
Cancer Res; 2004 Feb; 64(4):1278-86. PubMed ID: 14973063
[TBL] [Abstract][Full Text] [Related]
4. Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.
Foy RL; Chitalia VC; Panchenko MV; Zeng L; Lopez D; Lee JW; Rana SV; Boletta A; Qian F; Tsiokas L; Piontek KB; Germino GG; Zhou MI; Cohen HT
Hum Mol Genet; 2012 Dec; 21(26):5456-71. PubMed ID: 23001567
[TBL] [Abstract][Full Text] [Related]
5. Homology modeling and molecular dynamics simulation of the HIF2α degradation-related HIF2α-VHL complex.
Dong X; Su X; Yu J; Liu J; Shi X; Pan Q; Yang J; Chen J; Li L; Cao H
J Mol Graph Model; 2017 Jan; 71():116-123. PubMed ID: 27902963
[TBL] [Abstract][Full Text] [Related]
6. Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.
Liu J; Nussinov R
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):901-6. PubMed ID: 18195360
[TBL] [Abstract][Full Text] [Related]
7. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein.
Corn PG; McDonald ER; Herman JG; El-Deiry WS
Nat Genet; 2003 Nov; 35(3):229-37. PubMed ID: 14556007
[TBL] [Abstract][Full Text] [Related]
8. Structure, function and regulation of jade family PHD finger 1 (JADE1).
Panchenko MV
Gene; 2016 Sep; 589(1):1-11. PubMed ID: 27155521
[TBL] [Abstract][Full Text] [Related]
9. JADE1 is dispensable for the brain development in mice.
Wang J; Chai B; Yang Y; Chen C; Ren Y; Li Y; Wang ZQ; Li T
Biochem Biophys Res Commun; 2024 Feb; 695():149421. PubMed ID: 38171233
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
11. Beta-catenin gets jaded and von Hippel-Lindau is to blame.
Berndt JD; Moon RT; Major MB
Trends Biochem Sci; 2009 Mar; 34(3):101-4. PubMed ID: 19217300
[TBL] [Abstract][Full Text] [Related]
12. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
13. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940
[TBL] [Abstract][Full Text] [Related]
14. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.
Hergovich A; Lisztwan J; Barry R; Ballschmieter P; Krek W
Nat Cell Biol; 2003 Jan; 5(1):64-70. PubMed ID: 12510195
[TBL] [Abstract][Full Text] [Related]
15. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
He X; Wang J; Messing EM; Wu G
Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
[TBL] [Abstract][Full Text] [Related]
16. von Hippel-Lindau partner Jade-1 is a transcriptional co-activator associated with histone acetyltransferase activity.
Panchenko MV; Zhou MI; Cohen HT
J Biol Chem; 2004 Dec; 279(53):56032-41. PubMed ID: 15502158
[TBL] [Abstract][Full Text] [Related]
17. Proline hydroxylation at different sites in hypoxia-inducible factor 1α modulates its interactions with the von Hippel-Lindau tumor suppressor protein.
Qian H; Zou Y; Tang Y; Gong Y; Qian Z; Wei G; Zhang Q
Phys Chem Chem Phys; 2018 Jul; 20(27):18756-18765. PubMed ID: 29961792
[TBL] [Abstract][Full Text] [Related]
18. Jade-1: its structure, regulation and functions in the renal cancer.
Zhang YC; Du WQ; Zhang RY; Zheng JN; Pei DS
Curr Mol Med; 2016; 16(1):63-9. PubMed ID: 26695694
[TBL] [Abstract][Full Text] [Related]
19. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.
Lisztwan J; Imbert G; Wirbelauer C; Gstaiger M; Krek W
Genes Dev; 1999 Jul; 13(14):1822-33. PubMed ID: 10421634
[TBL] [Abstract][Full Text] [Related]
20. pVHL suppresses Akt/β-catenin-mediated cell proliferation by inhibiting 14-3-3ζ expression.
Castañeda A; Serrano C; Hernández-Trejo JA; Gutiérrez-Martínez IZ; Montejo-López W; Gómez-Suárez M; Hernández-Ruiz M; Betanzos A; Candelario-Martínez A; Romo-Parra H; Arias-Montaño JA; Schnoor M; Meraz Ríos MA; Gutierrez-Castillo ME; Martínez-Dávila IA; Villegas-Sepúlveda N; Martinez-Fong D; Nava P
Biochem J; 2017 Jul; 474(16):2679-2689. PubMed ID: 28666999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
